Zoetis (ZTS) Accounts Payables (2012 - 2026)
Zoetis (ZTS) posted quarterly Accounts Payables of $507.0 million for Q1 2026, up 20.71% year-over-year from $420.0 million in Q1 2025, and up 13.93% quarter-over-quarter from $445.0 million in Q4 2025.
Zoetis (ZTS) Accounts Payables (2012 - 2026) Analysis & Trends
Zoetis (ZTS) has reported Accounts Payables for 15 consecutive years, with $507.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Accounts Payables rose 20.71% year-over-year to $507.0 million; the TTM figure through Mar 2026 stood at $507.0 million (up 20.71% YoY), while the FY2025 annual figure was $445.0 million, up 2.77% from the prior year.
- Accounts Payables grew to $507.0 million in Q1 2026 per ZTS's latest filing, from $445.0 million in the prior quarter.
- Across five years, Accounts Payables topped out at $508.0 million in Q2 2025 and bottomed at $373.0 million in Q3 2022.
- Historically, Accounts Payables has averaged $426.4 million across 5 years, with a median of $420.0 million in 2024.
- Annual changes were most pronounced in 2024 — Accounts Payables decreased 9.48% — and 2025, when it advanced 20.95%.
- Zoetis' Accounts Payables stood at $405.0 million in 2022, then advanced by 1.48% to $411.0 million in 2023, then grew by 5.35% to $433.0 million in 2024, then increased by 2.77% to $445.0 million in 2025, then gained by 13.93% to $507.0 million in 2026.
- Business Quant data shows ZTS's Accounts Payables at $507.0 million in Q1 2026, $445.0 million in Q4 2025, and $410.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - | -5.09 Bn |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn | 2.72 Bn |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn | 452.00 Mn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn | 2.80 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn | 497.80 Mn |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn | 1.73 Bn |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn | 808.30 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | 427.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | 356.00 Mn |
| 10 | Alkermes | 8.21 Bn | 7.55 Bn | 397.90 Mn | 332.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 452.00 Mn |
| Mar 31, 2026 | 507.00 Mn |
| Dec 31, 2025 | 445.00 Mn |
| Sep 30, 2025 | 410.00 Mn |
| Jun 30, 2025 | 508.00 Mn |
| Mar 31, 2025 | 420.00 Mn |
| Dec 31, 2024 | 433.00 Mn |
| Sep 30, 2024 | 404.00 Mn |
| Jun 30, 2024 | 420.00 Mn |
| Mar 31, 2024 | 405.00 Mn |
| Dec 31, 2023 | 411.00 Mn |
| Sep 30, 2023 | 388.00 Mn |
| Jun 30, 2023 | 464.00 Mn |
| Mar 31, 2023 | 424.00 Mn |
| Dec 31, 2022 | 405.00 Mn |
| Sep 30, 2022 | 373.00 Mn |
| Jun 30, 2022 | 430.00 Mn |
| Mar 31, 2022 | 402.00 Mn |
| Dec 31, 2021 | 436.00 Mn |
| Sep 30, 2021 | 387.00 Mn |